Tianjin authorities visit Danish company’s production site
Print Edition
Chinese authorities have visited a site operated by Danish drugmaker Novo Nordisk A/S, the world’s biggest maker of insulin, the latest development in a widening investigation into Western drugmakers.
Novo said officials from the local Administration for Industry and Commerce visited a production facility in Tianjin on August 1.
“We were asked to provide information regarding our operations in China,” Chief Financial Officer Jesper Brandgaard said yesterday.
He said that whether it was a routine check, or triggered by the GSK investigation, was not clear. However, there had been no suggestions of any wrongdoing, he claimed.
- About Us
- |
- Terms of Use
- |
-
RSS - |
- Privacy Policy
- |
- Contact Us
- |
- Shanghai Call Center: 962288
- |
- Tip-off hotline: 52920043
- 沪ICP证：沪ICP备05050403号-1
- |
- 互联网新闻信息服务许可证：31120180004
- |
- 网络视听许可证：0909346
- |
- 广播电视节目制作许可证：沪字第354号
- |
- 增值电信业务经营许可证：沪B2-20120012
Copyright © 1999- Shanghai Daily. All rights reserved.Preferably viewed with Internet Explorer 8 or newer browsers.
